BILCAP: A randomized clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following curative surgery for biliary tract cancer.

被引：0
|
作者：
Bridgewater, J. A.
Stubbs, C.
Primrose, J. N.
机构：
[1] UCL, London, England
[2] Canc Res UK Clin Trials Unit CRCTU, Birmingham, W Midlands, England
[3] Southampton Gen Hosp, Southampton SO9 4XY, Hants, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4126
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Quality of life in the CRITICS study, a multicenter randomized phase III trial of neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy in resectable gastric cancer.
    Van Amelsfoort, Romy
    Walraven, Iris
    Jansen, Edwin P. M.
    Cats, Annemieke
    van Grieken, Nicole C. T.
    Aaronson, Neil K.
    Boot, Henk
    Lind, Pehr A.
    Kranenbarg, Elma Meershoek - Klein
    Nordsmark, Marianne
    Putter, Hein
    Trip, Anouk Kirsten
    van Sandick, Johanna W.
    Sikorska, Karolina
    van Tinteren, Harm
    Van De Velde, Cornelis J. H.
    Verheij, Marcel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] Randomized phase II crossover trial exploring the clinical benefit from targeting EGFR or VEGF with combination chemotherapy in patients with non-resectable biliary tract cancer.
    Jensen, Lars Henrik
    Fernebro, Eva
    Ploen, John
    Eberhard, Jakob
    Lindebjerg, Jan
    Jakobsen, Anders Kristian Moeller
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Phase III study of adjuvant chemotherapy versus surgery alone in radically resected gastric cancer. 5 year results of randomized study.
    Bajetta, E
    ANNALS OF ONCOLOGY, 2000, 11 : 64 - 64
  • [34] Quality of Life After Curative Resection for Rectal Cancer in Patients Treated With Adjuvant Chemotherapy Compared With Observation: Results of the Randomized Phase III SCRIPT Trial
    van der Valk, Maxime J. M.
    Hilling, Denise E.
    Kranenbarg, Elma Meershoek-Klein
    Peeters, Koen C. M. J.
    Kapiteijn, Ellen
    Tsonaka, Roula
    van de Velde, Cornelis J. H.
    Marang-van de Mheen, Perla J.
    DISEASES OF THE COLON & RECTUM, 2019, 62 (06) : 711 - 720
  • [35] Adjuvant Intra-Arterial Chemotherapy and Radiotherapy Versus Surgery Alone in Resectable Pancreatic and Periampullary Cancer A Prospective Randomized Controlled Trial
    Morak, Marjolein J. M.
    van der Gaast, Ate
    Incrocci, Luca
    van Dekken, Herman
    Hermans, John J.
    Jeekel, Johannes
    Hop, Wim C. J.
    Kazemier, Geert
    van Eijck, Casper H. J.
    ANNALS OF SURGERY, 2008, 248 (06) : 1031 - 1041
  • [36] Correction: A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT)
    Shin Kobayashi
    Masafumi Ikeda
    Kohei Nakachi
    Makoto Ueno
    Takuji Okusaka
    Akiko Todaka
    Sohei Satoi
    Akira Tomokuni
    Masaru Konishi
    Junji Furuse
    Annals of Surgical Oncology, 2023, 30 : 6651 - 6651
  • [37] Surgical complications related to peri-operative adjuvant chemotherapy in breast cancer. Results of a prospective, controlled, randomized clinical trial
    Canavese, G
    Catturich, A
    Vecchio, C
    Gipponi, M
    Tomei, D
    Sertoli, MR
    Repetto, L
    Badellino, F
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1997, 23 (01): : 10 - 12
  • [38] Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer. Results of a phase III randomized trial
    Grabenbauer, GG
    STRAHLENTHERAPIE UND ONKOLOGIE, 1998, 174 (02) : 108 - 109
  • [39] Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG
    Nitti, D
    Wils, J
    Dos Santos, JG
    Fountzilas, G
    Conte, PF
    Sava, C
    Tres, A
    Coombes, RC
    Crivellari, D
    Marchet, A
    Sanchez, E
    Bliss, JM
    Homewood, J
    Couvreur, ML
    Hall, E
    Baron, B
    Woods, E
    Emson, M
    Van Cutsem, E
    Lise, M
    ANNALS OF ONCOLOGY, 2006, 17 (02) : 262 - 269
  • [40] Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial
    Nanni, O.
    Amadori, D.
    De Censi, A.
    Rocca, A.
    Freschi, A.
    Bologna, A.
    Gianni, L.
    Rosetti, F.
    Amaducci, L.
    Cavanna, L.
    Foca, F.
    Sarti, S.
    Serra, P.
    Valmorri, L.
    Bruzzi, P.
    Corradengo, D.
    Gennari, A.
    Scaltriti, Laura
    Turolla, Gianni Michele
    Dazzi, Claudio
    Cortesi, Laura
    Giovanis, Petros
    Saracchini, Silvana
    Ciccarese, Mariangela
    Carrozza, Francesco
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 174 (02) : 433 - 442
12345